跳至主要内容
临床试验/NCT02513433
NCT02513433已完成不适用

Comparative Evaluation of Newer Congeners i.e. Levobupivacaine and Ropivacaine With Bupivacaine, in Lumbar Epidural Anaesthesia for Hip Surgeries

Government Medical College, Haldwani1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2012年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
Onset of sensory block

研究概览

简要总结

This study compares the clinical efficacy of newer local anaesthetic drugs Levobupivacaine and Ropivacaine with Bupivacaine in lumbar epidural anaesthesia for hip surgeries.

详细描述

Some of the most common day care surgeries are hip surgeries, in which local anaesthetic agents can be used via epidural route for both intra-op and post-op analgesia.

Among the drugs used nowadays are Lignocaine, Bupivacaine, Levobupivacaine and Ropivacaine.However Bupivacaine usage is not free from side effects.

The claimed benefits of both Levobupivacaine and Ropivacaine are reduced cardiac toxicity on overdose and more specific effects on sensory rather than motor nerve fibres.

Ropivacaine, an analog of Mepivacaine, is one of the long acting amide anaesthetic agent similar to Bupivacaine in chemical structure and anaesthetic function. It is a first enantiomer-specific compound, which has a reduced risk of cardio toxicity, neuro toxicity and rapid recovery of motor function. Levobupivacaine is the pure S (-)-enantiomer of Bupivacaine, and in recent year has emerged as a safer alternative for regional anaesthesia than its racemic parent.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • ASA Grade I and II patients of either sex
  • Age 18-60 years
  • Undergoing various hip surgeries under lumbar epidural anesthesia

排除标准

  • Refusal for epidural
  • ASA-III&IV
  • Head injury
  • Psychiatric disease
  • Known allergic to test drugs
  • Major systemic disease
  • Any analgesia with in past 24 hours

研究组 & 干预措施

Bupivacaine & Levobupivacaine

Active Comparator

Bupivacaine 15 ml 0.5% and Levobupivacaine 15 ml 0.5% in epidural route before surgery

干预措施: Bupivacaine (Drug)

Bupivacaine & Levobupivacaine

Active Comparator

Bupivacaine 15 ml 0.5% and Levobupivacaine 15 ml 0.5% in epidural route before surgery

干预措施: Levobupivacaine (Drug)

Bupivacaine & Ropivacaine

Active Comparator

Bupivacaine 15 ml 0.5% and Ropivacaine 15 ml 0.75% in epidural route before surgery

干预措施: Bupivacaine (Drug)

Bupivacaine & Ropivacaine

Active Comparator

Bupivacaine 15 ml 0.5% and Ropivacaine 15 ml 0.75% in epidural route before surgery

干预措施: Ropivacaine (Drug)

Ropivacaine & Levobupivacaine

Active Comparator

Ropivacaine 15 ml 0.75% and Levobupivacaine 15 ml 0.5% in epidural route before surgery

干预措施: Levobupivacaine (Drug)

Ropivacaine & Levobupivacaine

Active Comparator

Ropivacaine 15 ml 0.75% and Levobupivacaine 15 ml 0.5% in epidural route before surgery

干预措施: Ropivacaine (Drug)

结局指标

主要结局

Onset of sensory block

时间窗: 30 minutes

Time to achieve sensory block up to tenth thoracic dermatome

次要结局

  • Time to achieve maximum motor block(45 minutes)
  • Time for 2 segment regression of sensory block(90 minutes)

研究者

发起方
Government Medical College, Haldwani
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Subhro Mitra

Assistant Professor

Government Medical College, Haldwani

研究点 (1)

Loading locations...

相似试验